» Articles » PMID: 23559902

Mast Cell Density in Oral Submucous Fibrosis: a Possible Role in Pathogenesis

Overview
Specialty General Medicine
Date 2013 Apr 6
PMID 23559902
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Oral submucous fibrosis (OSMF) is a premalignant condition of oral cavity characterized by inflammation and progressive mucosal fibrosis. It has questionable pathogenesis. Mast cells (MC) have been associated with variety of inflammatory and fibrotic conditions, but little is known about their role in OSMF. Mast cells have been studied in normal gingiva, chronic inflammatory gingivitis, desquamative gingivitis, lichen planus, OSMF and oral cancer. Mast cells exhibit phenotypic plasticity. There is variation in the mast cell mediators with the change in the microenvironment, which makes the study of this cell in various diseases interesting.

Study Design: A retrospective study was conducted to find possible correlation between MC in 25 cases of OSF, 10 cases of oral squamous cell carcinoma (OSCC) and 10 cases of normal buccal mucosa by means of acidified toluidine blue staining method.

Results: The density of MC increased with disease progression. The densities of MC were significantly higher in OSMF than in normal buccal mucosa (p=0.001). The average numbers of MCs per square millimeter were 25, 49.50, 53.25 & 55.25 respectively.

Conclusion: The results suggest that MC have a definite role in initiation and progression of OSMF.

Citing Articles

Comparison of Mast Cell Count in Oral Epithelial Dysplasia and Squamous Cell Carcinoma.

Atarbashi-Moghadam S, Niazmand M, Vafadar S, Gholami Toghchi S J Dent (Shiraz). 2024; 25(4):369-373.

PMID: 39713112 PMC: 11662177. DOI: 10.30476/dentjods.2024.99652.2164.


Role of mast cells in the pathogenesis of oral submucous fibrosis: a systematic review and meta-analysis.

Bijai L, Aboalela A, Albalawi F, Khanagar S, Iyer K BMC Oral Health. 2024; 24(1):1219.

PMID: 39402549 PMC: 11476548. DOI: 10.1186/s12903-024-05025-8.


Enzyme-linked immunosorbent assay and immunohistochemical analysis of mast cell related biochemicals in oral submucous fibrosis.

Gharote H, Bhowate R, Dangore-Khasbage S F1000Res. 2024; 12:1288.

PMID: 38826574 PMC: 11140300. DOI: 10.12688/f1000research.141179.3.


Differential expression of cancer stem cell markers and pro-inflammatory cytokine IL-1β in the oral squamous cell carcinoma and oral submucosal fibrosis.

Awasthi S, Ahmad S, Gupta R, Iqbal M, Ahmad A Int J Health Sci (Qassim). 2023; 17(6):28-38.

PMID: 37929238 PMC: 10624801.


Mast cell expression in oral submucous fibrosis: A systematic review and metanalysis.

Gharote H, Bhowate R J Clin Exp Dent. 2023; 15(7):e571-e577.

PMID: 37519326 PMC: 10382163. DOI: 10.4317/jced.60234.


References
1.
Tsai C, Ma R, Shieh T . Deficiency in collagen and fibronectin phagocytosis by human buccal mucosa fibroblasts in vitro as a possible mechanism for oral submucous fibrosis. J Oral Pathol Med. 1999; 28(2):59-63. DOI: 10.1111/j.1600-0714.1999.tb01997.x. View

2.
Rao A . Idiopathic palatal fibrosis. Br J Surg. 1962; 50:23-5. DOI: 10.1002/bjs.18005021907. View

3.
DESA J . Submucous fibrosis of the palate and cheek. Ann Otol Rhinol Laryngol. 1957; 66(4):1143-59. DOI: 10.1177/000348945706600420. View

4.
PINDBORG J, Singh B . FORMATION OF VESICLES IN ORAL SUBMUCOUS FIBROSIS. Acta Pathol Microbiol Scand. 1964; 62:562-6. DOI: 10.1111/apm.1964.62.4.562. View

5.
Walsh L . Mast cells and oral inflammation. Crit Rev Oral Biol Med. 2003; 14(3):188-98. DOI: 10.1177/154411130301400304. View